Insider at

04

Insider transactions

05
1 buys (P) 0 sells (S) Net: $229,000 + 19 non-open-market transactions below Avg return of open purchases vs now: 403.5% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

19 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 12, 2026 ABSI P 100,000 $2.29 $229,000 421,446 Direct +31.11% Acquired 403.5% (price as of 2026-10-05)
July 28, 2025 ABSI P 50,000 $3.04 $152,000 327,264 Direct +18.03% Acquired 279.3% (price as of 2026-10-05)
Nov. 9, 2020 KRSA P 125,000 $2.53 $316,250 254,704 Direct +96.37% Acquired -91.3% (price as of 2026-10-05)
Nov. 15, 2019 KRSA P 125,000 $1.82 $227,500 125,000 Direct · Acquired -87.9% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 3, 2025 ABSI Stock Option (right to buy) Common Stock (93,700) $3.42 March 2, 2035 93,700 Acquired
Feb. 1, 2024 ABSI Stock Option (right to buy) Common Stock (349,625) $4.40 Jan. 31, 2034 349,625 Acquired
March 1, 2023 ABSI Stock Option (right to buy) Common Stock (550,000) $2.01 Feb. 28, 2033 550,000 Acquired
Oct. 3, 2022 ABSI Stock Option (right to buy) Common Stock (2,000,009) $2.97 Oct. 2, 2032 2,000,009 Acquired
June 8, 2022 ABSI Stock Option (right to buy) Common Stock (4,783) $3.39 June 7, 2032 4,783 Acquired
March 17, 2022 ABSI Stock Option (right to buy) Common Stock (45,180) $8.87 March 16, 2032 45,180 Acquired
Jan. 20, 2022 KRSA Employee Stock Option (Right to Buy) Common Stock (135,000) $1.21 Jan. 20, 2032 135,000 Acquired
Dec. 9, 2021 KRSA Employee Stock Option (Right to Buy) Common Stock (75,000) $1.93 Dec. 9, 2031 75,000 Acquired
Nov. 4, 2020 KRSA Employee Stock Option (Right to Buy) Common Stock (75,000) $2.48 Nov. 4, 2030 75,000 Acquired
Nov. 22, 2019 KRSA Employee Stock Option (Right to Buy) Common Stock (75,000) $2.01 Nov. 22, 2029 75,000 Acquired
April 29, 2019 KRSA Employee Stock Option (Right to Buy) Common Stock (300,000) $15.40 April 29, 2029 300,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ABSI

Ph.D. Chief Innovation Officer*
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $712,797 · $81,054 $239,422 $384,910 · $142,954 $1,561,137
2024 $654,095 · $365,750 $1,106,612 $392,457 · $125,506 $2,644,420
2023 $630,209 · $231,000 $787,419 $415,938 · $86,737 $2,151,303

KRSA

Ph.D.,*Chief Scientific Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $492,320 · · $113,183 $135,922 · $41,119 $782,544
2020 $479,667 · · $144,495 $138,144 · $44,613 $806,919

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.